Sanofi-Aventis S.A.
DGAP-WpÜG: Offeror: Sanofi-Aventis; Target: Hoechst AG (Part 1 of 2)
WpÜG-Mitteilung übermittelt durch die DGAP.
Für den Inhalt der Mitteilung ist der Bieter verantwortlich.
——————————————————————————–
Mandatory Publication pursuant to Sections 35 sub-sec. 1, 10 sub-sec. 3
Securities Acquisition and Takeover Act (WpÜG) – Mandatory Offer (Part 1 of 2)
Offeror:
Sanofi-Aventis
174 avenue de France
75013 Paris
France
ISIN FR 0000120578 (WKN 920 657)
Target:
Hoechst Aktiengesellschaft
Industriepark Hoechst, Gebäude K 701
Brüningstraße 50
65926 Frankfurt am Main
Germany
ISIN DE 0005758007 (WKN 575 800)
Other Companies directly affected by the Mandatory Offer:
Aventis
Cedex 9
67917 Strasbourg
France
ISIN FR 0000130460 (WKN 925 700)
Sanofi-Aventis, a French stock corporation (société anonyme), hereby announces
pursuant to Sections 35 sub-sec. 1, 10 sub-sec. 3 Securities Acquisition and
Take-over Act (“WpÜG”) that by acquisition of the majority of the shares and
voting rights of Aventis, a French stock corporation (société anonyme), on 20
August 2004, it gained indirect control in the meaning of Section 29 sub-sec.
2 WpÜG over Aventis’ subsidiary Hoechst Aktiengesellschaft
(ISIN DE 0005758007, WKN 575 800).
Aventis holds a total of 548,451,852 of the 559,153,690 shares of Hoechst
Aktiengesellschaft. This represents 98.09% of the registered share capital and
the voting rights in Hoechst Aktiengesellschaft.
Following the acquisition of the majority participation in Aventis these
voting rights in Hoechst Aktiengesellschaft are now attributed to Sanofi-
Aventis pursuant to Section 30 sub-sec. 1 sentence 1 no. 1 WpÜG.
Through the acquisition of the majority participation in Aventis by Sanofi-
Aventis on 20 August 2004, Total, a French stock corporation (société
anonyme), 2 place de la Coupole, 92078 Paris La Défense Cedex, France,
L’Oréal, a French stock corporation (société anonyme), 14 rue Royale, 75008
Paris, France, Téthys SAS, a French partnership limited by shares (société par
actions simplifiée), 14 rue Royale, 75008 Paris, France, Ms Liliane
Bettencourt, Mr André Bettencourt, Ms Françoise Bettencourt Meyers, Mr Jean-
Pierre Meyers (each of these individual shareholders with address at 14 rue
Royale, 75008 Paris, France), and Nestlé S.A., a Swiss stock corporation
(société anonyme), avenue Nestlé 55 CH-1800 Vevey, Switzerland, also gained
indirect control in the meaning of Section 29 sub-sec. 2 WpÜG over Hoechst
Aktiengesellschaft. The 548,451,852 shares or 98.09% of the voting rights in
Hoechst Aktiengesellschaft held by Aventis are also attributed to each of
Total, L’Oréal, Téthys SAS, Ms Liliane Bettencourt, Mr André Bettencourt, Ms
Françoise Bettencourt Meyers, Mr Jean-Pierre Meyers and Nestlé S.A. pursuant
to Section 30 sub-sec. 1 sentence 1 no. 1 WpÜG.
Satisfying its obligations and the obligations of Total, L’Oréal, Téthys SAS,
Ms Liliane Bettencourt, Mr André Bettencourt, Ms Françoise Bettencourt Meyers,
Mr Jean-Pierre Meyers and Nestlé S.A. resulting from Section 35 WpÜG, Sanofi-
Aventis will make a mandatory offer to the outside shareholders of Hoechst
Aktiengesellschaft.
Subsequent to the approval by the German Federal Financial Supervisory
Authority (Bundesanstalt für Finanzdienstleistungsaufsicht) the offer document
for the mandatory offer will be published pursuant to Sections 35 sub-sec. 2,
14 sub-sec. 3 sentence 1 no. 1 WpÜG on the Internet at
http://www.sanofi-aventis.com and by public announcement of its free of charge
availability.
Sanofi-Aventis reserves the right to purchase shares in Hoechst
Aktiengesellschaft outside the mandatory offer as permitted under German law,
provided such purchases shall not violate any applicable securities laws of
any other jurisdiction. The offer document and announcements posted on the
internet at http://www.sanofi-aventis.com will contain further information
about any such purchases outside the mandatory offer.
This announcement is neither an offer to purchase nor a solicitation of an
offer to sell securities of Hoechst Aktiengesellschaft. The offer will be
contained in the offer document which will contain additional important
information.
End part 1 of 2
Ende der Mitteilung (c)DGAP 23.08.2004
——————————————————————————–
Notiert: Sanofi-Aventis: Freiverkehr in Berlin-Bremen, Frankfurt, Hamburg,
Hannover, München und Stuttgart; Hoechst AG: Amtlicher Markt in Frankfurt
(General Standard); Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, Hannover,
München und Stuttgart; Aventis S.A.: Amtlicher Markt in Frankfurt (General
Standard); Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, Hannover, München,
Stuttgart; Paris
231224 Aug 04
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found